Feed AMPH
AM

Amphastar Pharmaceuticals, Inc.

AMPH · NASDAQ

$26.13 -1.10% (-$0.29)
1M +19.42%
Market Cap $1.16B
P/E Ratio 14.75x
Div. Yield -
ROE 10.11%

Bulios Fair Price

$20.31

22.3% downside

Current Price

$26.13

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AMPH is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
90 /100
Cheap
P/E 14.75x
P/B 1.51x
EV/EBITDA 9.29x
Growth
76 /100
Growing
EPS growth 5.27%
Book val. growth 14.27%
Rev. growth 12.99%
Profitability
82 /100
Strong
Gross margin 47.68%
FCF margin 20.94%
Net margin 10.76%
Quality
38 /100
Average
ROIC 5.90%
Asset turnover 0.42x
ROE 10.11%
Debt
59 /100
Moderate
Debt/Equity 0.90x
Net debt/EBITDA 2.66x
Current ratio 2.40x
Stability
75 /100
Stable
Beta 0.92x
Profitable years 6
Rev. volatility 15.40%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AMPH
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yongfeng Zhang

Employees

1,976

Headquarters

Rancho Cucamonga

Upcoming events

05 NOV

Earnings

Upcoming earnings report

40d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.